Results 21 to 30 of about 21,844 (159)

Impact of vaccine effectiveness and coverage on preventing large mumps outbreaks on college campuses: Implications for vaccination strategy

Epidemics, 2022
Recent mumps outbreaks among highly vaccinated populations, including college students, have called into question the vaccine effectiveness (VE) of routine two-dose measles, mumps, and rubella (MMR2) immunization. We aimed to estimate the VE required for
Michael Melgar, Bryan Yockey, Mariel Asbury Marlow   +2 more
doaj   +1 more source

Mumps and mumps vaccine: A global review [PDF]

The Indian Journal of Pediatrics, 1999
Mumps is an acute infectious disease caused by a paramyxovirus. Although the disease is usually mild, up to 10% of patients can develop aseptic meningitis; a less common but more serious complication is encephalitis, which can result in death or disability. Permanent deafness, orchitis, and pancreatitis are other untoward effects of mumps.
A M, Galazka, S E, Robertson, A, Kraigher   +2 more
openaire   +3 more sources

A mumps model with seasonality in China

Infectious Disease Modelling, 2017
Background: Mumps, an infectious viral disease, classically manifested by inflammation of salivary glands and is best known as a common childhood viral disease with no specific treatment.
Qianqian Qu, Cong Fang, Le Zhang, Wanru Jia, Jie Weng, Yong Li   +5 more
doaj   +1 more source

Parents’ views on mumps, mumps vaccine, and the factors associated with vaccination in Japan

Vaccine, 2021
The measles-mumps-rubella vaccine was withdrawn from the National Immunization Program in 1993 because aseptic meningitis was reported as a post-vaccination adverse reaction in Japan. This study aimed to measure the uptake of and determinants influencing mumps vaccination, including concerns about adverse reactions.We conducted this cross-sectional ...
Megumi, Hara, Rie, Koshida, Takashi, Nakano   +2 more
openaire   +2 more sources

Safety and immunological effectiveness of the domestic combined trivaccine for the prevention of measles, rubella and mumps Vaktrivir^® in children 12 months and 6 years of age (results of a simple blind multicenter comparative randomized clinical trial)

Эпидемиология и вакцинопрофилактика, 2021
Relevanc. Measles, mumps and rubella, despite many years of vaccination, retain their epidemiological and social significance at the present time. The aim of the work is to study the safety and immunogenicity. Of the vaccine for the prevention of measles,
I. V. Feldblium, V. V. Romanenko, K. A. Subbotina, M. G. Menshikova, I. A. Okuneva, A. Y. Musikhina, T. E. Snitkovskaya, N. I. Marcovich, A. E. Ershov, D. M. Trofimov   +9 more
doaj   +1 more source

Antibody responses to Hepatitis B and measles-mumps-rubella vaccines in children who received chemotherapy for acute lymphoblastic leukemia

Revista Brasileira de Hematologia e Hemoterapia, 2012
OBJECTIVE: To evaluate viral vaccine antibody levels in children with acute lymphoblastic leukemia after chemotherapy and after vaccine booster doses.
Simone Santana Viana, Gustavo Santos Araujo, Gustavo Baptista de Almeida Faro, Lana Luíza da Cruz-Silva, Carlos André Araújo-Melo, Rosana Cipolotti   +5 more
doaj   +1 more source

Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults

Vaccines, 2022
Mumps outbreaks and breakthrough infections of measles and rubella have raised concerns about waning of vaccine-induced immunity after two doses of measles-mumps-rubella (MMR) vaccination.
Patricia Kaaijk, Alienke J. Wijmenga-Monsuur, Hinke I. ten Hulscher, Jeroen Kerkhof, Gaby Smits, Mioara Alina Nicolaie, Marianne A. van Houten, Rob S. van Binnendijk   +7 more
doaj   +1 more source

Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients

mBio, 2020
The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against coronavirus disease 2019 (COVID-19). Our aim was to determine whether any MMR IgG titers are inversely correlated with severity in recovered COVID-19 patients ...
Jeffrey E. Gold, William H. Baumgartl, Ramazan A. Okyay, Warren E. Licht, Paul L. Fidel, Mairi C. Noverr, Larry P. Tilley, David J. Hurley, Balázs Rada, John W. Ashford   +9 more
doaj   +1 more source

Effectiveness of an outbreak dose of mumps-containing vaccine in two First Nations communities in Northern Ontario, Canada

Human Vaccines & Immunotherapeutics, 2022
Between 18 Dec 2017 and 27 June 2018, a mumps outbreak occurred in two Canadian Indigenous communities. An outbreak dose of mumps-containing vaccine was offered as part of control measures.
Wallis Rudnick, Sarah Wilson, Jo Ann Majerovich, Michelle Haavaldsrud, Marene Gatali, Cai-Lei Matsumoto, Shelley Deeks   +6 more
doaj   +1 more source

Assessment of mumps-containing vaccine effectiveness during an outbreak: Importance to introduce the 2-dose schedule for China

Human Vaccines & Immunotherapeutics, 2018
Introduction: China has used 3 different mumps-containing vaccines (MuCV) since 1990: monovalent mumps vaccine, measles–mumps (MM) vaccine, and measles–mumps–rubella (MMR) vaccine, and one dose MuCV (using MMR at 18 months) has been included in the EPI ...
Chao Ma, Yan Liu, Jihai Tang, Haimei Jia, Wei Qin, Ying Su, Huaqing Wang, Lixin Hao   +7 more
doaj   +1 more source